STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

PMGC Holdings Announces Share Repurchases from Existing Shareholders

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

PMGC Holdings (NASDAQ: ELAB) has announced the repurchase of shares from select existing shareholders who directly approached the company. The transactions' details are documented in Form 8-K filings available on sec.gov.

The company states it will evaluate additional share repurchase opportunities from other investors, subject to market conditions. Interested shareholders are instructed to submit written requests to PMGC's Newport Beach headquarters.

PMGC emphasizes this is not a formal share repurchase program or tender offer, and future repurchases remain at the company's discretion in response to unsolicited shareholder inquiries.

Loading...
Loading translation...

Positive

  • Company demonstrates financial capacity to repurchase shares
  • Selective share repurchases may help support stock price

Negative

  • Lack of structured buyback program indicates commitment to systematic share repurchases
  • Selective nature of repurchases may create unequal treatment among shareholders

NEWPORT BEACH, Calif., March 21, 2025 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (the “Company,” “PMGC,” “we,” or “our”) today announced that it has repurchased shares from certain existing shareholders who contacted the Company directly. Details of these transactions are available in the Company’s Form 8-K filings on www.sec.gov.

The Company will consider repurchasing additional shares from other investors who wish to sell, subject to market conditions and other considerations.

Shareholders interested in discussing potential repurchases are encouraged to contact the Company directly in writing and mail request the company's headquarters in Newport Beach, California.

This press release does not constitute an offer to purchase or a solicitation of an offer to sell any securities. The Company is not conducting a formal share repurchase program or tender offer. Any repurchases of shares referenced herein were made in response to unsolicited shareholder inquiries and may or may not occur in the future, at the Company’s sole discretion.

About PMGC Holdings Inc.

PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. Currently, our portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. We are committed to exploring opportunities in multiple sectors to maximize growth and value. For more information, please visit https://www.pmgcholdings.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as “believes,” “expects,” “plans,” “potential,” “would” and “future” or similar expressions such as “look forward” are intended to identify forward-looking statements. Forward-looking statements are made as of the date of this press release and are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results. Therefore, you should not rely on any of these forward-looking statements. These and other risks are described more fully in PMGC Holdings’ filings with the United States Securities and Exchange Commission (“SEC”), including the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on March 29, 2024, and its other documents subsequently filed with or furnished to the SEC. Investors and security holders are urged to read these documents free of charge on the SEC’s web site at www.sec.gov. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, the Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

IR Contact:
IR@pmgcholdings.com


FAQ

What type of share repurchases did PMGC Holdings (ELAB) announce on March 21, 2025?

PMGC announced selective share repurchases from existing shareholders who contacted the company directly, not a formal repurchase program.

How can shareholders sell their ELAB shares back to PMGC Holdings?

Shareholders must submit written requests to PMGC's Newport Beach headquarters for consideration of potential share repurchases.

Where can investors find details about PMGC Holdings' (ELAB) recent share repurchase transactions?

Details of the share repurchase transactions are available in PMGC's Form 8-K filings on www.sec.gov.

Is PMGC Holdings (ELAB) conducting a formal share buyback program?

No, PMGC is not conducting a formal share repurchase program or tender offer; repurchases are made in response to unsolicited shareholder inquiries.
PMGC Holdings

NASDAQ:ELAB

ELAB Rankings

ELAB Latest News

ELAB Latest SEC Filings

ELAB Stock Data

3.93M
676.01k
11.41%
2.22%
5.4%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEWPORT BEACH